BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6142601)

  • 1. Pharmacological and behavioural studies of benzodiazepine antagonists and contragonists.
    Nutt D
    Adv Biochem Psychopharmacol; 1983; 38():153-73. PubMed ID: 6142601
    [No Abstract]   [Full Text] [Related]  

  • 2. Distinct behavioral and pharmacological effects of two benzodiazepine antagonists: Ro 15-1788 and methyl beta-carboline.
    Prado de Carvalho L; Venault P; Cavalheiro E; Kaijima M; Valin A; Dodd RH; Potier P; Rossier J; Chapouthier G
    Adv Biochem Psychopharmacol; 1983; 38():175-87. PubMed ID: 6142602
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioral and EEG effects of benzodiazepines and their antagonists in the cat.
    Ongini E
    Adv Biochem Psychopharmacol; 1983; 38():211-25. PubMed ID: 6142604
    [No Abstract]   [Full Text] [Related]  

  • 4. Blockade of behavioral effects of bretazenil by flumazenil and ZK 93,426 in pigeons.
    Witkin JM; Acri JB; Gleeson S; Barrett JE
    Pharmacol Biochem Behav; 1997 Jan; 56(1):1-7. PubMed ID: 8981602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CGS 8216 fails to modify novelty-related behaviour in mice: further evidence for differential actions of benzodiazepine antagonists.
    Rodgers RJ; Clemmitt M
    Neurosci Lett; 1984 Oct; 51(2):161-3. PubMed ID: 6151155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of GABA in the facilitation of punishment suppressed behavior induced by beta-carbolines in rat.
    Corda MG; Costa E; Guidotti A
    Adv Biochem Psychopharmacol; 1983; 38():121-7. PubMed ID: 6322536
    [No Abstract]   [Full Text] [Related]  

  • 7. The benzodiazepine receptor inverse agonists beta-CCM and RO 15-3505 both reverse the anxiolytic effects of ethanol in mice.
    Belzung C; Misslin R; Vogel E
    Life Sci; 1988; 42(18):1765-72. PubMed ID: 2896286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-regulation of ICSS duration: effects of anxiogenic substances, benzodiazepine antagonists and antidepressants.
    Gerhardt S; Liebman JM
    Pharmacol Biochem Behav; 1985 Jan; 22(1):71-6. PubMed ID: 2858109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic bretazenil produces tolerance to chlordiazepoxide, midazolam, and abecarnil.
    Bronson ME
    Pharmacol Biochem Behav; 1995; 51(2-3):481-90. PubMed ID: 7667373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of benzodiazepine antagonists.
    Haefely W
    Pharmacopsychiatry; 1985 Jan; 18(1):163-6. PubMed ID: 2859619
    [No Abstract]   [Full Text] [Related]  

  • 11. What can be learned from the effects of benzodiazepines on exploratory behavior?
    File SE
    Neurosci Biobehav Rev; 1985; 9(1):45-54. PubMed ID: 2858081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do the intrinsic actions of benzodiazepine receptor antagonists imply the existence of an endogenous ligand for benzodiazepine receptors?
    File SE; Pellow S
    Adv Biochem Psychopharmacol; 1986; 41():187-202. PubMed ID: 3017069
    [No Abstract]   [Full Text] [Related]  

  • 13. Behavioural evidence for partial agonist properties of RO 15-1788, a benzodiazepine receptor antagonist.
    Dantzer R; PĂ©rio A
    Eur J Pharmacol; 1982 Jul; 81(4):655-8. PubMed ID: 6811297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The assessment of the action of pharmacological agents based on a new computer program for analysing animal operant behavior].
    Garibova TL; Voronina TA; Stefankov DV; Kalinina TS
    Farmakol Toksikol; 1990; 53(1):67-70. PubMed ID: 1970311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzodiazepines and their antagonists: a pharmacoethological analysis with particular reference to effects on "aggression".
    Rodgers RJ; Waters AJ
    Neurosci Biobehav Rev; 1985; 9(1):21-35. PubMed ID: 2858079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the benzodiazepine antagonist Ro 15-1788 reverse the actions of picrotoxin and pentylenetetrazole on social and exploratory behaviour?
    File SE; Pellow S
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):272-9. PubMed ID: 2865937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ro 16-6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptor.
    Martin JR; Pieri L; Bonetti EP; Schaffner R; Burkard WP; Cumin R; Haefely WE
    Pharmacopsychiatry; 1988 Nov; 21(6):360-2. PubMed ID: 2907644
    [No Abstract]   [Full Text] [Related]  

  • 18. New concepts in the neurobiology of anxiety.
    Skolnick P; Paul SM
    J Clin Psychiatry; 1983 Nov; 44(11 Pt 2):12-20. PubMed ID: 6315689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sites of action for anxiogenic drugs: behavioural, electrophysiological and biochemical correlations.
    Pellow S; File SE
    Psychopharmacology (Berl); 1984; 83(4):304-15. PubMed ID: 6093178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further assessment of benzodiazepine-tricyclic antidepressant interaction. Effectiveness of combined treatment with ketazolam-nortriptyline on conflict behaviour in rats.
    Cannizzaro G; Brucato AF; Provenzano PM
    Arzneimittelforschung; 1982; 32(9):1111-3. PubMed ID: 6128985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.